
David Miklos, MD, discusses exciting data for the use of chimeric antigen receptor T-cell therapy as treatment of patients with diffuse large B-cell lymphoma.

Your AI-Trained Oncology Knowledge Connection!


Published: April 15th 2020 | Updated:

Published: March 14th 2019 | Updated: